Cervical Cancer Screening in HIV Positive and Negative Women in Cambodia
NCT ID: NCT02253719
Last Updated: 2015-10-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1000 participants
OBSERVATIONAL
2014-10-31
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cervical Cancer Screening by Self-sampling in a Cohort of Younger Women in Ethiopia
NCT05125380
Screening Test Accuracy of Gynocularâ„¢, HR-HPV Testing, VIA for Detection of Cervical Neoplastic Lesions, in Women Living With HIV
NCT03931083
ASPIRE Pilot: Comparing Self-collected HPV Testing With Visual Inspection With Acetic Acid Screening for Cervical Cancer
NCT02029794
Cervical Cancer Screening of Postmenopausal Women in Low- and Middle-income Countries Using HPV Self-sampling and Triage by Genotyping and Cytology
NCT07244315
Cervical Cancer Screening in Cameroon
NCT04401670
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HIV positive women
500 HIV women will be recruited from the hospital's current patient base as well as the community
cryotherapy, further biopsy, LEEP, surgery as indicated
These interventions and their outcomes are not part of this study. However, we will be offering at no charge appropriate treatment for neoplasia or cancer that is diagnosed.
HIV negative women
500 HIV women will be recruited from the hospital's current patient base as well as the community
cryotherapy, further biopsy, LEEP, surgery as indicated
These interventions and their outcomes are not part of this study. However, we will be offering at no charge appropriate treatment for neoplasia or cancer that is diagnosed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cryotherapy, further biopsy, LEEP, surgery as indicated
These interventions and their outcomes are not part of this study. However, we will be offering at no charge appropriate treatment for neoplasia or cancer that is diagnosed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
30 Years
49 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sihanouk Hospital Center of HOPE
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thay Sovanarra, MD
Role: PRINCIPAL_INVESTIGATOR
Sihanouk Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sihanouk Hospital, St. 134, Sangkat Vealvong, Khan 7 Makara
Phnom Pehn, , Cambodia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SHCH-Cervical Screening-VIA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.